Seamless Therapeutics

About:

Seamless Therapeutics is reshaping the gene editing paradigm with a novel approach to restoring health in patients.

Top Investors: Wellington Partners, Forbion Capital Partners, GO-Bio

Description:

Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Seamless technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes.

Total Funding Amount:

23.6M EUR

Headquarters Location:

Dresden, Sachsen, Germany

Founded Date:

2022-01-01

Contact Email:

info(AT)seamlesstx.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-04-23

IPO Status:

Private

Industries: